An 8-year-old boy suffering from a congenital heart disease was operated upon in a coordinated manner by doctors of four departments in the King George's Medical University (KGMU). Wikimedia Commons
MedBound Blog

Four KGMU Depts Join Hands to Save Boy Suffering from Heart Disease

An 8-year-old boy suffering from a congenital heart disease was operated upon in a coordinated manner by doctors of four departments in the King George's Medical University (KGMU).

MBT Desk

According to the KGMU spokesman, the child was diagnosed with Teratology of Fallot that affects normal blood flow through the heart.

An 8-year-old boy suffering from a congenital heart disease was operated upon in a coordinated manner by doctors of four departments in the King George's Medical University (KGMU).

The boy, a resident of Sitapur district, came to hospital with difficulty in breathing and oxygen saturation of 50 to 60 per cent. He was admitted to the paediatrics department under Prof Mala and Dr Shalini.

According to the KGMU spokesman, the child was diagnosed with Teratology of Fallot that affects normal blood flow through the heart.

After 10 days of exhaustive ICU management, the boy has recovered.

"The illness is a type of cyanotic congenital heart disease (CHD) and babies do not survive for long. It has incidence rate of 0.34 per 1000 live births," said Prof S.K. Singh of the department of cardiac surgery.

Four departments -- paediatrics, cardiology, cardiac anaesthesia and cardiac surgery -- came together to save the child.

The challenge was to do open heart surgery in minutes as the kid was on bare minimum oxygen levels inside the operating theatre.

After 10 days of exhaustive ICU management, the boy has recovered. "The boy will lead a normal life now," said Prof Singh. (NS/NewsGram)


Hurry up! Join the Medical Internship 3.0 at MedBound!

India’s Triumph Over Polio: A Public Health Milestone

GTB Doctor Urges CAQM to Exempt Vehicles for People with Disabilities

When Stress Hijacks Your Memories, Why Safe Feels Scary!

Severe COVID-19 Infection May Lead to Tumor Shrinkage, New Study Finds

First mRNA Norovirus Vaccine Enters Trial to Combat Global Health Crisis